H.R. 2820 — Referred from Senate

IIB 114th CONGRESS 1st Session H. R. 2820 IN THE SENATE OF THE UNITED STATES September 9, 2015Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions AN ACT To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. 1. Short title This Act may be cited as the Stem Cell Therapeutic and Research Reauthorization Act of 2015. 2. Amendments to the Stem Cell Therapeutic and Research Act of 2005 (a) Cord blood inventory Section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended in subsection (h)— (1) in paragraph (1)— (A) by striking $23,000,000 for each of fiscal years 2011 through 2014 and; and (B) by inserting before the period at the end the following: and $23,000,000 for each of fiscal years 2016 through 2020; and (2) in paragraph (2), by striking 2011 through 2015 and inserting 2015 through 2020. (b) National program Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking 2011 through 2014 and inserting 2016 through 2020. Passed the House of Representatives September 8, 2015.Karen L. Haas,Clerk